Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized single-blind multicenter trial of esflurbiprofen patches for knee osteoarthritis
CTR20251264Phase 3Active
- Sponsor
- 九典制药
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of esflurbiprofen in knee osteoarthritis (OA), sponsored by 九典制药. Started Apr 2025; status: active.
02
Drugs
esflurbiprofen
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on CTR20251264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251264.